Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Zalutumumab> ?p ?o }
Showing triples 1 to 98 of
98
with 100 triples per page.
- Zalutumumab abstract "Zalutumumab (proposed trade name HuMax-EGFr) is a fully human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFr). It is a product developed by Genmab in Utrecht, the Netherlands. Specifically, zalutumumab is designed for the treatment of squamous cell carcinoma of the head and neck (SCCHN), a type of cancer. The current treatment for SCCHN includes tyrosine kinase inhibitors and human monoclonal antibodies.".
- Zalutumumab atcPrefix "none".
- Zalutumumab casNumber "667901-13-5".
- Zalutumumab wikiPageID "9701109".
- Zalutumumab wikiPageLength "6977".
- Zalutumumab wikiPageOutDegree "50".
- Zalutumumab wikiPageRevisionID "691517518".
- Zalutumumab wikiPageWikiLink Angiogenesis.
- Zalutumumab wikiPageWikiLink Antibody-dependent_cell-mediated_cytotoxicity.
- Zalutumumab wikiPageWikiLink Apoptosis.
- Zalutumumab wikiPageWikiLink Atomic_mass_unit.
- Zalutumumab wikiPageWikiLink Binding_domain.
- Zalutumumab wikiPageWikiLink C-Raf.
- Zalutumumab wikiPageWikiLink CD16.
- Zalutumumab wikiPageWikiLink Cancer.
- Zalutumumab wikiPageWikiLink Category:Monoclonal_antibodies_for_tumors.
- Zalutumumab wikiPageWikiLink Cell_adhesion.
- Zalutumumab wikiPageWikiLink Cell_cycle.
- Zalutumumab wikiPageWikiLink Cell_migration.
- Zalutumumab wikiPageWikiLink Chemotherapy.
- Zalutumumab wikiPageWikiLink Competitive_antagonist.
- Zalutumumab wikiPageWikiLink Elk-1.
- Zalutumumab wikiPageWikiLink Epidermal_growth_factor.
- Zalutumumab wikiPageWikiLink Epidermal_growth_factor_receptor.
- Zalutumumab wikiPageWikiLink Extracellular_signal-regulated_kinases.
- Zalutumumab wikiPageWikiLink FDA_Fast_Track_Development_Program.
- Zalutumumab wikiPageWikiLink Food_and_Drug_Administration.
- Zalutumumab wikiPageWikiLink Fragment_antigen-binding.
- Zalutumumab wikiPageWikiLink Fragment_crystallizable_region.
- Zalutumumab wikiPageWikiLink GRB2.
- Zalutumumab wikiPageWikiLink Genmab.
- Zalutumumab wikiPageWikiLink Guanosine_diphosphate.
- Zalutumumab wikiPageWikiLink Guanosine_triphosphate.
- Zalutumumab wikiPageWikiLink Head_and_neck_cancer.
- Zalutumumab wikiPageWikiLink Inverse_agonist.
- Zalutumumab wikiPageWikiLink Lipophilicity.
- Zalutumumab wikiPageWikiLink Lymphocyte.
- Zalutumumab wikiPageWikiLink Metastasis.
- Zalutumumab wikiPageWikiLink Mitogen-activated_protein_kinase_kinase.
- Zalutumumab wikiPageWikiLink Monoclonal_antibody.
- Zalutumumab wikiPageWikiLink Natural_killer_cell.
- Zalutumumab wikiPageWikiLink P21-activated_kinases.
- Zalutumumab wikiPageWikiLink Phosphorylation.
- Zalutumumab wikiPageWikiLink Progression-free_survival.
- Zalutumumab wikiPageWikiLink Protein_dimer.
- Zalutumumab wikiPageWikiLink Protein_phosphatase_2A.
- Zalutumumab wikiPageWikiLink Ras_subfamily.
- Zalutumumab wikiPageWikiLink Receptor_tyrosine_kinase.
- Zalutumumab wikiPageWikiLink Squamous-cell_carcinoma.
- Zalutumumab wikiPageWikiLink Statistical_significance.
- Zalutumumab wikiPageWikiLink Survival_rate.
- Zalutumumab wikiPageWikiLink TGF_alpha.
- Zalutumumab wikiPageWikiLink Tyrosine-kinase_inhibitor.
- Zalutumumab wikiPageWikiLink Utrecht.
- Zalutumumab wikiPageWikiLinkText "HuMax-EGFR".
- Zalutumumab wikiPageWikiLinkText "Zalutumumab".
- Zalutumumab wikiPageWikiLinkText "zalutumumab".
- Zalutumumab atcPrefix "none".
- Zalutumumab c "6512".
- Zalutumumab casNumber "667901".
- Zalutumumab chemspiderid "none".
- Zalutumumab h "10074".
- Zalutumumab kegg "D10031".
- Zalutumumab mabType "mab".
- Zalutumumab molecularWeight "148".
- Zalutumumab n "1734".
- Zalutumumab o "2032".
- Zalutumumab s "46".
- Zalutumumab source "u".
- Zalutumumab target Epidermal_growth_factor_receptor.
- Zalutumumab type "mab".
- Zalutumumab verifiedfields "changed".
- Zalutumumab verifiedrevid "470635509".
- Zalutumumab wikiPageUsesTemplate Template:Cascite.
- Zalutumumab wikiPageUsesTemplate Template:Chemspidercite.
- Zalutumumab wikiPageUsesTemplate Template:Cn.
- Zalutumumab wikiPageUsesTemplate Template:Drugbankcite.
- Zalutumumab wikiPageUsesTemplate Template:Drugbox.
- Zalutumumab wikiPageUsesTemplate Template:Keggcite.
- Zalutumumab wikiPageUsesTemplate Template:Monoclonals_for_tumors.
- Zalutumumab wikiPageUsesTemplate Template:Reflist.
- Zalutumumab subject Category:Monoclonal_antibodies_for_tumors.
- Zalutumumab type ChemicalSubstance.
- Zalutumumab type Drug.
- Zalutumumab type Antibody.
- Zalutumumab type Chemical.
- Zalutumumab type Drug.
- Zalutumumab type Redirect.
- Zalutumumab type ChemicalObject.
- Zalutumumab type Thing.
- Zalutumumab type Q8386.
- Zalutumumab comment "Zalutumumab (proposed trade name HuMax-EGFr) is a fully human IgG1 monoclonal antibody (mAb) directed towards the epidermal growth factor receptor (EGFr). It is a product developed by Genmab in Utrecht, the Netherlands. Specifically, zalutumumab is designed for the treatment of squamous cell carcinoma of the head and neck (SCCHN), a type of cancer. The current treatment for SCCHN includes tyrosine kinase inhibitors and human monoclonal antibodies.".
- Zalutumumab label "Zalutumumab".
- Zalutumumab sameAs Q8065569.
- Zalutumumab sameAs m.02ppk_l.
- Zalutumumab sameAs Q8065569.
- Zalutumumab wasDerivedFrom Zalutumumab?oldid=691517518.
- Zalutumumab isPrimaryTopicOf Zalutumumab.